Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

OPPA regimen

View Patient Information

A regimen consisting of vincristine, prednisone, procarbazine and doxorubicin (OPPA) used in combination with radiation therapy for the treatment of female patients with childhood Hodgkin lymphoma with low-risk features.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	GPOH-HD 95 regimen Oncovin-prednisone-procarbazine-Adriamycin regimen OPPA

OPPA regimen

Search NCI's Drug Dictionary